Shanghai ZJ Bio-Tech Co., Ltd (SHA:688317)
China flag China · Delayed Price · Currency is CNY
16.93
-0.01 (-0.06%)
Sep 4, 2026, 3:00 PM CST

Shanghai ZJ Bio-Tech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-65.04-34.3-127.46-136.86760.27758.52
Depreciation & Amortization
65.2665.2768.466.6960.2424.84
Other Amortization
1.821.830.720.590.08-
Loss (Gain) From Sale of Assets
0.15-0.04-0.04--0.03-
Asset Writedown & Restructuring Costs
9.260.4322.531.150.590.03
Loss (Gain) From Sale of Investments
-7.56-6.18-0.06---
Provision & Write-off of Bad Debts
0.390.398.411.366.355.38
Other Operating Activities
49.4519.25134.73169.99-62.7628.33
Change in Accounts Receivable
7.8927.8837.31114.7712.17-25.19
Change in Inventory
7.5110.5136.3731.72-297.19-172.51
Change in Accounts Payable
-8.41-10.98-81.05-304.21104.4916.72
Change in Other Net Operating Assets
-1.590.730.980.611.185.86
Operating Cash Flow
52.6366.8577.59-81.88584.97641.94
Operating Cash Flow Growth
-18.41%-13.84%---8.87%-43.78%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-22.23-1.99-19.49-81.15-74.56-498.06
Sale of Property, Plant & Equipment
0.630.630.011.140.06-
Investment in Securities
0.51-305.360.062.32-1.53-21
Other Investing Activities
0.46-----
Investing Cash Flow
-20.63-306.72-19.42-77.69-76.02-519.06

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-297----
Long-Term Debt Repaid
--5.22-2.51-3.65-3.75-
Lease Payments
-2.24-2.24-2.51-3.65-3.75-
Net Debt Issued (Repaid)
89.82291.78-2.51-3.65-3.75-
Issuance of Common Stock
-----1,959
Repurchase of Common Stock
-259.11-259.11-35.33--102.03-
Common Dividends Paid
-5.91-3.03-20.88-230.74-265.62-311.53
Other Financing Activities
138.11-----19.3
Financing Cash Flow
-37.0929.64-58.72-234.39-371.41,628

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-51.28-23.0114.4415.7774.35-19.82
Net Cash Flow
-56.37-233.2413.89-378.19211.91,731

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
30.464.8658.1-163.03510.41143.88
Free Cash Flow Growth
-51.32%11.63%--254.76%-86.52%
Free Cash Flow Margin
25.65%51.96%32.52%-59.43%21.94%7.13%
Free Cash Flow Per Share
0.180.360.30-0.852.640.76
Levered Free Cash Flow
17.0143.1542.13-98.85410.82-144.71
Unlevered Free Cash Flow
19.1945.3342.35-98.63411.11-144.71
Free Cash Flow After Leases
28.1762.6255.6-166.68506.66143.88

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
--12.1817.2152.97188.93261.3
Change in Working Capital
-1.120.21-29.64-184.81-179.76-175.17